Purpose: Systemic corticosteroids represent the standard treatment of autoimmune pancreatitis with IgG4-associated cholangitis. In patients who are steroiddependent, azathioprine has been reported for maintenance of remission. Mycophenolate mofetil and rituximab have been suggested as alternative therapies in patients who fail or who are intolerant of azathioprine. However, there are no reports to date in the English literature on the use of mycophenolate mofetil in adult patients with autoimmune pancreatitis. A patient with autoimmune pancreatitis refractory to steroids and intolerant of azathioprine was treated with mycophenolate mofetil, whose mechanism of action is inhibition of de novo guanine synthesis and blockade of both B and T lymphocyte production. Introduction of mycophenolate mofetil and uptitration to 1000 mg by mouth twice daily over a treatment period of four months was associated with improvement in the patient's energy level and blood glucose control and was not associated with any adverse events. The patient was managed without a biliary stent. However, there was a return of symptoms, jaundice, elevation in the transaminases, and hyperbilirubinemia when the prednisone dose was tapered to 11 mg per day. In the first case report of mycophenolate mofetil use in an adult patient with IgG4-associated autoimmune pancreatitis and cholangiopathy, the introduction of mycophenolate mofetil was safe and was well-tolerated without side effects or adverse events. The introduction appeared to result in initial clinical improvement (energy, control of hyperglycemia) but did not enable taper of steroid therapy below 11 mg per day. Mycophenolate mofetil and other immunomodulatory therapies should continue to be studied for maintenance of remission in the large subset of patients with refractory or recurrent autoimmune pancreatitis.
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Acute Cholecystitis at Initial Presentation of Polyarteritis Nodosa Sepideh Farzin Moghadam, MD, Dilhana Badurdeen, MD, Duane Smoot, MD, Rahana Begum, MD. howard university hospital, WASHINGTON, DC. Purpose: Polyarteritis nodosa (PAN) is a necrotizing, focal segmental vasculitis that affects medium-sized arteriesis of unknown etiology. Although gastrointestinal involvement may be seen in 14-53% of the cases of PAN. This is very rare entity as initial onset in gallbladder disorder, and can be presented as acalculous cholecystitis. Methods: The patient is a 51-year-old female who presents to the emergency room with a chief complains of diffuse abdominal pain, associated with nausea and vomiting. Over the last month, she noticed weight loss (15 pounds), generalized myalgia and fever. She had a history of hypertension. At physical examination she presented with fever, abdominal tenderness. Blood pressure was 178/92 mmHg. Abdominal ultrasonography disclosed thickening of the gallbladder wall, without any cholelithiasis. On this occasion, the laboratory exams showed a hemoglobin level of 11.3 g/dl, a total white blood cell count of 11.9 x 10 3 cells/mm 3 (84% neuthrophils). The level of liver function test, amylase, lipase were in normal limits. ESR was elevated. ANA, anti-DNA, serology for HBV, HCV all was negative. The preoperative diagnosis was acute cholecystitis and she underwent cholecystectomy. On histologic examination pathology results with microscopic finding was acute-on-chronic vasculitis with necrosis and thrombosis of mucosal vessels. Final diagnosis was acute acalculous cholecystitis secondary to vasculitis , mostly consistent with PAN. Results: We report a patient with acute abdominal pain due to vasculitis of the gallbladder at onset of disease. Although there were no evidence of systemic involvement, she fulfilled the ACR criteria for classification of PAN. Conclusion: PAN was first described in its classic form by Kussmaul in 1866. Polyartritis nodosa involving the gallbladder is extremely uncommon and because of its rarity, the natural history of gallbladder vasculitis is not well defined. 1.6-2.7% gallbladder vasculitis has been reported. Chen et al. in 1989 found only five cases of vasculitis of gallbladder in a large series of surgical specimens. Only 2 out of 120 (1.6%) patients with classic PAN developed cholecystitis in series studied by Generau et al in 1997. Reports regarding isolated and self-limited vasculitis affecting the gallbladder have been described. Whether such involvement is an early manifestation of systemic disease or a distinct pathologic entity is not well established. Differential diagnosis between both forms of PAN is frequently based on clinical and laboratorial grounds. The therapeutic approach to the isolated form of PAN is controversial. While a few reports have demonstrated no progression of the disease after long term follow-up, others have reported death in some untreated cases. Rachana Potru, MD, Clyde Collins, MD, Vinay Sood, DO. Albany Medical College, Albany, NY. Purpose: Pancreatic cysts are often identified incidentally on body imaging. Cysts >3 cm are often evaluated by endoscopic ultrasound (EUS), and those <1 cm followed by serial imaging. We present two cases in which EUS of pancreatic cysts <1.5 cm in size revealed nonfunctioning pancreatic neuroendocrine tumors (PNET). A 36-year-old man presented with an exacerbation of chronic epigastric pain. He also reported subjective fevers, skin flushing and pruritus. Computed tomography (CT) of the abdomen and pelvis showed a subcentimeter hypodensity in the body of pancreas. EUS showed a thick walled, anechoic, single compartment cyst in the pancreatic body measuring 10 x 7 mm. Fine needle aspiration (FNA) was consistent with a well-differentiated neuroendocrine tumor. Nuclear octreotide scan and hormonal studies were normal and the tumor was determined to be localized and nonfunctioning. A 59-year-old man presented with two weeks of right flank pain. CT scan revealed a 1.5 cm exophytic cystic area in the tail of the pancreas contiguous with the posterior wall of the stomach. EUS showed a 15 x 15 mm anechoic, multicystic, distally enhancing lesion with peripheral mural nodularity in the pancreatic tail. FNA revealed neoplasm and the patient underwent distal pancreatectomy and splenectomy. Surgical resection specimen pathology showed a low-grade PNET with negative margins. Lymph nodes sampled were negative for malignancy and this was determined to be a nonfunctioning neuroendocrine tumor. Pancreatic cysts are increasingly discovered as abdominal
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Rare Presentation of Cystic Nonfunctioning Pancreatic Neuroendocrine Tumor: A Case-Series
